Innovative Respiratory Tech Aluna specializes in AI-powered spirometer devices combined with a mobile app for chronic respiratory management, presenting an attractive solution for healthcare providers seeking advanced, patient-friendly lung health monitoring tools.

Strategic Industry Expansion Following its acquisition by Huma Therapeutics, Aluna is poised to expand its presence in the U.S. market, offering opportunities for sales collaborations with clinics, hospitals, and telehealth providers interested in integrated respiratory health solutions.

Strong Funding Support With a recent Series B funding of $15.3 million led by major investors like Matrix Partners and SOSV, Aluna is financially well-positioned to invest in product scaling and to establish partnerships with healthcare organizations focused on respiratory care.

Partnership Opportunities Aluna has already partnered with ModuleMD, a practice management SaaS for allergists and pulmonologists, indicating a strategic openness to collaborative integrations—ideal for sales teams targeting health tech platforms seeking complementary respiratory monitoring tools.

Market Trends & Potential The growing demand for remote health monitoring solutions and the rising prevalence of respiratory conditions make Aluna’s platform a timely fit for telehealth providers, insurance companies, and employer health programs looking to enhance respiratory disease management.